AlternativeMed
Relationship Graph Explorer

Follow the connections

Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.

Plus 6,743 TCM formulas connecting herbs together
⚗️ Ingredient

Enoxaparin

5
Clinical Trials
22
Meta-Analyses
0
PubMed References
📋 Sample Trials
NCT05225155
Effect of Prophylatic Use of Enoxaparin in Women Undergoing in Vitro Fertilization Treatment
Completed
NCT05334654
Bivalirudin Versus Enoxaparin in Critically Ill COVID-19 Patients
Completed
NCT05265676
Bioequivalence Study of a Generic Enoxaparin Sodium to Clexane® After Single Subcutaneous Dose in Healthy Human Subjects
Completed · Phase 1
📊 Sample Meta-Analyses
CRD42016039951
Apixaban versus enoxaparin for thromboprophylaxis in patients undergoing total knee replacement (TKR) and total hip replacement (THR)
Total knee replacement (TKR) is the treatment of choice in patients suffering fr
CRD42018090050
<div>The safety and effectiveness of enoxaparin and aspirin for extended venous thromboembolism prophylaxis after total hip and knee arthroplasty: a systematic review</div>
Prevention of deep vein thrombosis and pulmonary embolism in patients who have u
CRD42019104205
Comparison of direct oral anticoaugulants and enoxaparin for preventing major vascular events after total hip or knee replacement: a network meta-analysis
Total hip or knee replacement surgery, postoperative vascular events.
📚 Sample References
None linked yet.
⚗️ All Ingredient data fields for Enoxaparin
⚗️ Identity
Name
Enoxaparin
Aliases / Synonyms
Clexane; Clivarin; Nadroparine; Ardeparin; Bemiparin; Certoparin; Clivarine; Dalteparin; Fraxiparin
🧪 Chemistry
Molecular Weight
1134.9340
LogP
-10.7119
Drug-likeness
0.047
H-Bond Acceptors
30
H-Bond Donors
15
Rotatable Bonds
21
🔬 Structures
Canonical SMILES
CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O
Isomeric SMILES
CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O
InChIKey
HTTJABKRGRZYRN-UHFFFAOYSA-N
InChI
InChI=1S/C26H42N2O37S5/c1-4(30)27-7-9(31)13(6(56-23(7)39)3-55-67(43,44)45)58-26-19(65-70(52,53)54)12(34)16(20(62-26)22(37)38)60-24-8(28-66(40,41)42)15(63-68(46,47)48)14(5(2-29)57-24)59-25-18(64-69(49,50)51)11(33)10(32)17(61-25)21(35)36/h5-20,23-26,28-29,31-34,39H,2-3H2,1H3,(H,27,30)(H,35,36)(H,37,38)(H,40,41,42)(H,43,44,45)(H,46,47,48)(H,49,50,51)(H,52,53,54)
🔗 External References
PubChem CID
NPASS
NPC305261
TCMID
23123
🔍 Raw view — every non-empty column on this row (28 fields)
name
Enoxaparin
common names
Clexane; Clivarin; Nadroparine; Ardeparin; Bemiparin; Certoparin; Clivarine; Dalteparin; Fraxiparin
herb ingredient id
HBIN025099
canonical smiles
CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O
isomeric smiles
CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O
inchi
InChI=1S/C26H42N2O37S5/c1-4(30)27-7-9(31)13(6(56-23(7)39)3-55-67(43,44)45)58-26-19(65-70(52,53)54)12(34)16(20(62-26)22(37)38)60-24-8(28-66(40,41)42)15(63-68(46,47)48)14(5(2-29)57-24)59-25-18(64-69(49,50)51)11(33)10(32)17(61-25)21(35)36/h5-20,23-26,28-29,31-34,39H,2-3H2,1H3,(H,27,30)(H,35,36)(H,37,38)(H,40,41,42)(H,43,44,45)(H,46,47,48)(H,49,50,51)(H,52,53,54)
inchikey
HTTJABKRGRZYRN-UHFFFAOYSA-N
mol wt
1134.9340
num h acceptors
30
num h donors
15
mol logp
-10.7119
num rotatable bonds
21
drug likeness
0.047
tcmid ingredient id
23123
pubchem cid
772
npass id
NPC305261

🏥 Linked Health Topics

1 · diseases via target pathways

📋 Clinical Trials

5 · subject of clinical study
NCT05225155 Effect of Prophylatic Use of Enoxaparin in Women Undergoing in Vitro Fertilizati
→ Infertility, Female|Thrombophilia|Fertilization in
NCT05334654 Bivalirudin Versus Enoxaparin in Critically Ill COVID-19 Patients
→ Acute Respiratory Failure|SARS CoV 2 Infection|Ant
NCT05265676 Bioequivalence Study of a Generic Enoxaparin Sodium to Clexane® After Single Sub
→ Healthy
NCT05224388 Evaluating Dose Regimen of Intravenous Unfractionated Heparin and Low Molecular
→ COVID-19|Deep Vein Thrombosis|Anticoagulants and B
NCT05226793 Medication Use Evaluation for Enoxaparin in Hospitalized COVID-19 Patients
→ Venous Thromboembolism

📊 Meta-Analyses

12 · systematic review
CRD42016039951 Apixaban versus enoxaparin for thromboprophylaxis in patients undergoing total k
→ Total knee replacement (TKR) is the treatment of c
CRD42018090050 <div>The safety and effectiveness of enoxaparin and aspirin for extended venous
→ Prevention of deep vein thrombosis and pulmonary e
CRD42019104205 Comparison of direct oral anticoaugulants and enoxaparin for preventing major va
→ Total hip or knee replacement surgery, postoperati
CRD42020138958 A systematic review of economic evaluation of rivaroxaban versus enoxaparin for
→ Venous thromboembolism (VTE) refers to a blood clo
CRD42020153712 Enoxaparin vs unfractionated heparin for the prevention of venous thromboembolis
→ Venous thromboembolism
CRD42020156278 Enoxaparin versus unfractionated heparin during percutaneous coronary interventi
→ Coronary heart disease (CHD).
CRD42020179955 Efficacy and safety of enoxaparin or fondaparinux in COVID-19 patients: a living
→ The condition to be studied is COVID-19, a novel h
CRD42020220379 Prophylactic Enoxaparin Dosing by Anti-Xa trough levels in reducing Venous Throm
→ Venous thromboembolism (VTE) poses a significant c
CRD42021236062 Use of Enoxaparin (LMWH) and its efficacy in Neurosurgical Patients: literature
CRD42021266102 Efficacy and safety of enoxaparin versus new oral anticoagulants to prevent veno
→ Total hip replacement (THR) is an effective and co
CRD42021267438 Use of Enoxaparin (LMWH) and it’s efficacy in Trauma Patients - Should anti-fact
CRD42021270070 Enoxaparin and it’s efficacy in Spinal Surgical Patients – Should anti-factor Xa
How relationships are computed
  • Clinical Trials / Meta-Analyses / References: direct foreign-key link via subject_entity_id (Phase 2d wireup)
  • Formula ↔ Herbs: text bridge via formulas.herbs_in_pinyin matching herbs.pinyin_name
  • Herb ↔ Ingredient: ACTIVE — direct link via herb_ingredients
  • Ingredient ↔ Target: ACTIVE — direct link via ingredient_targets
  • Target ↔ Disease: ACTIVE — direct link via target_health_topics
  • Herb → Target → Disease (full chemical spine): ACTIVE — joins all three link tables